Literature DB >> 19268746

Peripheral arterial function in infants and young children with one-ventricle physiology and hypoxemia.

Shobha Natarajan1, Christian Heiss, Yerem Yeghiazarians, Jeffrey R Fineman, David F Teitel, Theresa A Tacy.   

Abstract

Patients with 1-ventricle (1V) physiology may be at risk for peripheral arterial dysfunction at a young age. To determine whether infants and young children with 1V physiology and hypoxemia have peripheral arterial dysfunction before undergoing the Fontan operation, we measured (1) flow-mediated vasodilation (FMD) in the brachial artery, (2) serum levels of vasoactive mediators endothelin-1 (ET-1) and metabolites of nitric oxide, and (3) arterial stiffness with pulse-wave velocity (PWV) in the aorta. Eighteen patients with 1V physiology before the Fontan procedure and hypoxemia and 19 patients with normoxemia and 2-ventricle (2V) physiology were studied. Measurements were collected during cardiac catheterization. FMD in the brachial artery was the diameter gain after 4.5 minutes of forearm occlusion measured with high-resolution ultrasound and edge-detection software. Nitric oxide and ET-1 levels were measured in venous blood. PWV between the left carotid and femoral arteries was measured using pulse Doppler ultrasound. FMD was lower (2.4 +/- 3.7% vs 11.3 +/- 6%, p <0.0005) and ET-1 levels were higher (35.5 +/- 11.3% vs 24.1 +/- 9.7%, p = 0.003) in subjects with 1V physiology versus those with 2V physiology, respectively. There were no differences in nitric oxide levels or PWV. In conclusion, infants and young children with 1V physiology and hypoxemia have blunted FMD and higher ET-1 levels before undergoing the Fontan operation compared with normoxemic subjects with 2V physiology. A further understanding of pathophysiologic mechanisms underlying peripheral arterial dysfunction, including the roles of hypoxemia, low cardiac index, and ET-1, may lead to targeted therapies and improve the long-term survival of patients with 1V physiology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19268746     DOI: 10.1016/j.amjcard.2008.11.059

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Elevated Aortic Augmentation Index in Children Following Fontan Palliation: Evidence of Stiffer Arteries?

Authors:  Deepti P Bhat; Pooja Gupta; Sanjeev Aggarwal
Journal:  Pediatr Cardiol       Date:  2015-04-02       Impact factor: 1.655

Review 2.  Central role of eNOS in the maintenance of endothelial homeostasis.

Authors:  Christian Heiss; Ana Rodriguez-Mateos; Malte Kelm
Journal:  Antioxid Redox Signal       Date:  2014-12-10       Impact factor: 8.401

Review 3.  Hypoplastic left heart syndrome: current considerations and expectations.

Authors:  Jeffrey A Feinstein; D Woodrow Benson; Anne M Dubin; Meryl S Cohen; Dawn M Maxey; William T Mahle; Elfriede Pahl; Juan Villafañe; Ami B Bhatt; Lynn F Peng; Beth Ann Johnson; Alison L Marsden; Curt J Daniels; Nancy A Rudd; Christopher A Caldarone; Kathleen A Mussatto; David L Morales; D Dunbar Ivy; J William Gaynor; James S Tweddell; Barbara J Deal; Anke K Furck; Geoffrey L Rosenthal; Richard G Ohye; Nancy S Ghanayem; John P Cheatham; Wayne Tworetzky; Gerard R Martin
Journal:  J Am Coll Cardiol       Date:  2012-01-03       Impact factor: 24.094

4.  Arterial stiffness in adult patients after Fontan procedure.

Authors:  Lidia Tomkiewicz-Pajak; Hanna Dziedzic-Oleksy; Jacek Pajak; Maria Olszowska; Jacek Kolcz; Monika Komar; Piotr Podolec
Journal:  Cardiovasc Ultrasound       Date:  2014-04-10       Impact factor: 2.062

5.  The effect of bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study.

Authors:  Anders Hebert; Annette S Jensen; Lars Idorn; Keld E Sørensen; Lars Søndergaard
Journal:  BMC Cardiovasc Disord       Date:  2013-05-11       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.